GSE171882
RNA-Seq analysis (long-reads) of human parental M238P and BRAF inhibitors-resistant M238R melanoma cells
M238P BRAFV600E mutant melanoma cells sensitive to the BRAF inhibitor Vemurafenib (PLX4032) and the corresponding resistant M238R cell line were cultured in standard conditions. RNA samples were then harvested and sequenced with the Nanopore long-reads protocol. Overall design: 2 samples: M238P versus M238R